Reflow Medical Receives CE Mark for Bare Temporary Spur Stent System for Treating de novo or Restenotic Below-the-Knee (BTK) Lesions
Reflow Medical, Inc., a developer of innovative medical devices focused on cardiovascular disease, announces it has received CE (Conformité Européenne) Mark certification in the European Union for the Bare Temporary Spur Stent System .
- Reflow Medical, Inc., a developer of innovative medical devices focused on cardiovascular disease, announces it has received CE (Conformité Européenne) Mark certification in the European Union for the Bare Temporary Spur Stent System .
- The device is intended to treat de novo or restenotic lesions in the infrapopliteal arteries with a commercially available drug-coated balloon (DCB) to enhance drug absorption.
- View the full release here: https://www.businesswire.com/news/home/20240116803175/en/
The Bare Temporary Spur Stent System is a unique clinical solution known as Retrievable Stent Therapy, or RST. - The Bare Temporary Spur Stent System is a unique clinical solution intended to provide stent-like results while leaving no metal behind.